Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225497429> ?p ?o ?g. }
- W4225497429 endingPage "363" @default.
- W4225497429 startingPage "353" @default.
- W4225497429 abstract "Patients with psoriasis have a high risk for multiple comorbid conditions. However, few studies have examined the association between psoriasis and severe and rare infections. This study reports the incidence of severe and rare infections (considered as rare in Denmark) among Danish patients with psoriasis, compared with the general population.The objectives of this study were to assess the incidence and risk of severe and rare infections in Danish patients with psoriasis and the matched general population, and to compare this risk for patients with severe or mild psoriasis with that of the general population.Data for individuals aged ≥18 years who were alive and resident in the source population were collected from the Danish National Patient Register between 1 January 1997 and 31 December 2018. Individuals with any of the investigated chronic infections prior to inclusion were excluded. Patients with psoriasis were matched (1 : 6) for age and sex with general population controls. Severe infections were defined as infections requiring treatment in a hospital setting and rare infections included HIV, hepatitis B and C, and tuberculosis infections. Incidence rates (IRs) were reported per 100 000 person-years of exposure. Severe psoriasis was defined according to previous or active use of systemic or biological treatment. Patients who never received biological and/or systemic treatment were categorized as having mild psoriasis.A total of 94 450 patients with psoriasis were matched with 566 700 controls. The respective IRs were higher for patients with any psoriasis compared with controls; IR 3104·9 [95% confidence interval (CI) 3066·6 to 3143·7] and IR 2381·1 (95% CI 2367·6 to 2394·6) for any infection, IR 3080·6 (95% CI 3042·5 to 3119·3) and IR 2364·4 (95% CI 2350·9 to 2377·9) for severe infections, and IR 42·9 (95% CI 38·89 to 47·4) and IR 31·8 (95% CI 30·34 to 33·3) for rare infections, respectively. Patients with severe psoriasis had higher IRs of severe or rare infections (IR 3847·7, 95% CI 3754·3 to 3943·4) compared with patients with mild psoriasis and controls.As the severity of psoriasis increases, so does the risk of severe and rare infections. Therefore, clinicians should be aware of the increased risk of severe and rare infections in patients with severe psoriasis so that early investigation and treatment can be initiated. What is already known about this topic? Few studies have looked at the incidence and prevalence of serious infections (associated with hospitalization) and rare infections including tuberculosis, hepatitis B and C, and HIV among patients with different severities of psoriasis. What does this study add? Patients with psoriasis have an increased risk of severe and rare infections. Clinicians should be aware of the increased risk of severe and rare infections in patients with severe psoriasis so that early investigation and treatment can be initiated." @default.
- W4225497429 created "2022-05-05" @default.
- W4225497429 creator A5009079207 @default.
- W4225497429 creator A5009118689 @default.
- W4225497429 creator A5038618637 @default.
- W4225497429 creator A5052211962 @default.
- W4225497429 creator A5083173532 @default.
- W4225497429 creator A5083499602 @default.
- W4225497429 date "2022-09-01" @default.
- W4225497429 modified "2023-09-30" @default.
- W4225497429 title "A nationwide population-based cohort study of the incidence of severe and rare infections among adults with psoriasis in Denmark" @default.
- W4225497429 cites W1521666696 @default.
- W4225497429 cites W1530625745 @default.
- W4225497429 cites W1539727108 @default.
- W4225497429 cites W1964975614 @default.
- W4225497429 cites W1968179324 @default.
- W4225497429 cites W1978670003 @default.
- W4225497429 cites W1988093201 @default.
- W4225497429 cites W2013886298 @default.
- W4225497429 cites W2021018799 @default.
- W4225497429 cites W2064809740 @default.
- W4225497429 cites W2076116648 @default.
- W4225497429 cites W2110427394 @default.
- W4225497429 cites W2125574991 @default.
- W4225497429 cites W2142749836 @default.
- W4225497429 cites W2165294669 @default.
- W4225497429 cites W2166811019 @default.
- W4225497429 cites W2219591537 @default.
- W4225497429 cites W2275338442 @default.
- W4225497429 cites W2407999733 @default.
- W4225497429 cites W2515659207 @default.
- W4225497429 cites W2524008969 @default.
- W4225497429 cites W2541013163 @default.
- W4225497429 cites W2741785503 @default.
- W4225497429 cites W2797152839 @default.
- W4225497429 cites W2907171532 @default.
- W4225497429 cites W2967383980 @default.
- W4225497429 cites W2968264741 @default.
- W4225497429 cites W2978322033 @default.
- W4225497429 cites W3008617419 @default.
- W4225497429 cites W3013968235 @default.
- W4225497429 cites W3015610507 @default.
- W4225497429 cites W3046573040 @default.
- W4225497429 cites W3135029142 @default.
- W4225497429 cites W3185691303 @default.
- W4225497429 doi "https://doi.org/10.1111/bjd.21595" @default.
- W4225497429 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35383888" @default.
- W4225497429 hasPublicationYear "2022" @default.
- W4225497429 type Work @default.
- W4225497429 citedByCount "6" @default.
- W4225497429 countsByYear W42254974292022 @default.
- W4225497429 countsByYear W42254974292023 @default.
- W4225497429 crossrefType "journal-article" @default.
- W4225497429 hasAuthorship W4225497429A5009079207 @default.
- W4225497429 hasAuthorship W4225497429A5009118689 @default.
- W4225497429 hasAuthorship W4225497429A5038618637 @default.
- W4225497429 hasAuthorship W4225497429A5052211962 @default.
- W4225497429 hasAuthorship W4225497429A5083173532 @default.
- W4225497429 hasAuthorship W4225497429A5083499602 @default.
- W4225497429 hasBestOaLocation W42254974292 @default.
- W4225497429 hasConcept C107130276 @default.
- W4225497429 hasConcept C120665830 @default.
- W4225497429 hasConcept C121332964 @default.
- W4225497429 hasConcept C126322002 @default.
- W4225497429 hasConcept C16005928 @default.
- W4225497429 hasConcept C187212893 @default.
- W4225497429 hasConcept C201903717 @default.
- W4225497429 hasConcept C2780564577 @default.
- W4225497429 hasConcept C2908647359 @default.
- W4225497429 hasConcept C61511704 @default.
- W4225497429 hasConcept C71924100 @default.
- W4225497429 hasConcept C72563966 @default.
- W4225497429 hasConcept C99454951 @default.
- W4225497429 hasConceptScore W4225497429C107130276 @default.
- W4225497429 hasConceptScore W4225497429C120665830 @default.
- W4225497429 hasConceptScore W4225497429C121332964 @default.
- W4225497429 hasConceptScore W4225497429C126322002 @default.
- W4225497429 hasConceptScore W4225497429C16005928 @default.
- W4225497429 hasConceptScore W4225497429C187212893 @default.
- W4225497429 hasConceptScore W4225497429C201903717 @default.
- W4225497429 hasConceptScore W4225497429C2780564577 @default.
- W4225497429 hasConceptScore W4225497429C2908647359 @default.
- W4225497429 hasConceptScore W4225497429C61511704 @default.
- W4225497429 hasConceptScore W4225497429C71924100 @default.
- W4225497429 hasConceptScore W4225497429C72563966 @default.
- W4225497429 hasConceptScore W4225497429C99454951 @default.
- W4225497429 hasFunder F4320307778 @default.
- W4225497429 hasIssue "3" @default.
- W4225497429 hasLocation W42254974291 @default.
- W4225497429 hasLocation W42254974292 @default.
- W4225497429 hasLocation W42254974293 @default.
- W4225497429 hasOpenAccess W4225497429 @default.
- W4225497429 hasPrimaryLocation W42254974291 @default.
- W4225497429 hasRelatedWork W2021018799 @default.
- W4225497429 hasRelatedWork W2033458234 @default.
- W4225497429 hasRelatedWork W2060022074 @default.
- W4225497429 hasRelatedWork W2084290125 @default.
- W4225497429 hasRelatedWork W2139693734 @default.